Stock PGC PARAGON CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Paragon Care Limited

Equities

PGC

AU000000PGC4

Market Closed - Australian S.E.
Other stock markets
 07:10:05 08/05/2024 BST 		5-day change 1st Jan Change
0.355 AUD +2.90% Intraday chart for Paragon Care Limited +9.23% +57.78%
03-18 Paragon Care Appoints Interim CFO MT
03-18 ParagonCare Appoints Interim CFO MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company's earnings growth outlook lacks momentum and is a weakness.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PARAGON CARE LIMITED Stock Paragon Care Limited
+57.78% 152M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.19% 185B
C+
MEDTRONIC PLC Stock Medtronic plc
-1.08% 109B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.23% 68.54B
A
DEXCOM, INC. Stock DexCom, Inc.
+3.43% 51.74B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.33% 45.22B
B-
HOYA CORPORATION Stock Hoya Corporation
+3.12% 41.74B
B+
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.54% 26.83B
A-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+4.10% 26.69B
B
TERUMO CORPORATION Stock Terumo Corporation
+11.62% 25.63B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PGC Stock
  4. Ratings Paragon Care Limited